| Stage | CLX | % of rev | BF.B | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.9B | 100.00% | $1.2B | 100.00% | CLX ×1.65 |
| Gross profit | $804M | 41.27% | $549M | 46.49% | BF.B +5.2pp |
| Operating income | $258M | 13.24% | $252M | 21.34% | BF.B +8.1pp |
| Pre-tax income | $213M | 10.93% | $229M | 19.39% | BF.B +8.5pp |
| Net income | $167M | 8.57% | $176M | 14.90% | BF.B +6.3pp |
| Stage | CLX | BF.B | Gap · A − B |
|---|---|---|---|
| Revenue | $1.9B100.00% | $1.2B100.00% | CLX ×1.65 |
| Gross profit | 41.27%$804M | 46.49%$549M | BF.B +5.2pp |
| Operating income | 13.24%$258M | 21.34%$252M | BF.B +8.1pp |
| Pre-tax income | 10.93%$213M | 19.39%$229M | BF.B +8.5pp |
| Net income |
| 8.57%$167M |
| 14.90%$176M |
| BF.B +6.3pp |